News

In July 2008, Maxygen sold the recombinant factor VIIa product candidate to Bayer along with its other hematology assets for an upfront cash payment of $90m. Under the

The three new formulations include Super Green Coffee extract, Green Coffee Bean Extract Lean and Green Coffee Bean Extract Cleanse. Each Super Green Coffee capsule provides 800mg 100%

Trial Interactive offers access to global project documentation, get rid of much of the travel and shipping associated with TMF reviews and reconciliation and provide a metrics dashboard.

AR-42 is a broad-spectrum deacetylation inhibitor of both histone and non-histone proteins. The orally available inhibitor has demonstrated greater potency and activity in solid tumours and hematological malignancies

Liquid Health Business Development director Brett Peterson said the demand for liquid alternatives of popular vitamin products has skyrocketed in 2012. "African Mango studies have shown great promise

The trial evaluated vedolizumab in 1,115 Crohn’s disease patients who have failed at least one conventional therapy, including TNFa antagonists. Takeda General Medicine (Gastrointestinal and Genitourinary) vice president

GLPG0634 is a novel Janus kinase 1 (JAK1) inhibitor being developed to treat multiple autoimmune diseases. Galapagos chief scientific officer Piet Wigerinck said the proof of concept study

The new methods will produce high-purity populations of neural stem cells (NSC) from hpSC and their therapeutically valuable derivatives at a low cost. The method is capable of

ABH’s wholly owned subsidiary, Angel Biomedical Ltd (ABL) will take ownership of the manufacturing plant. The 6,500ft² facility comprises one large Grade C clean room, two smaller grade